Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 3, 2000

View Archived Issues

Research links autoantibodies to the symptoms of Sjogren's syndrome

New findings on an old drug: metformin

Possible connection between intestinal bacteria and autism revealed

Amiloride fails to show benefit in cystic fibrosis trial

Magainin receives patent for novel obesity compound

New technology may improve safety in testing of adenovirus-based gene therapies

Licensing opportunity from NIH: methods of gene targeting

Adeno-associated virus vector available for licensing from NIH

Licensing opportunity from NIH: AAV4 and its use for gene delivery

NIH offers apoptosis-inducing gene product for licensing

Licensing opportunity from NIH: replication-deficient retroviral vectors

Overexpression of UCP-3 results in reduced tissue mass in mice

Inconclusive results obtained with desferrioxamine in multiple sclerosis trial

Roche seeks approval of Tamiflu in Japan

Bayer's Cipro recommended for approval in treating anthrax exposure

Acadia granted phase I SBIR award for neuropsychiatric research

Concerta approved by FDA, licensed worldwide by Alza

Bavarian Nordic initiates phase I/II trial of metastatic malignant melanoma treatment

New compounds under development at AHP for treatment of inflammatory and autoimmune diseases

JNK protein kinase inhibitors under study at Roche

New selective dopamine D4 receptor antagonists useful for psychosis and schizophrenia

Antibacterial agents under development at British Biotech

New compounds interacting with 5-HT1A receptors useful for depression, etc.

New polypeptides useful for Chlamydia infection

New human lymphocytic membrane proteins under study at Incyte

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...